出来高 | 11,185 |
|
|||||
ニュース | - | ||||||
今日の高値 | 1.07 | 安値 高値 |
|||||
今日の安値 | 1.01 |
企業情報 - Oragenics Inc
時価総額 | 発行済株式数 | Float | 歳入 | 利益/損失 | 一株当たり利益 | PER |
---|---|---|---|---|---|---|
0 | 2.57M | - | 38k | -20.66M | - | - |
Short Interest | 1株あたり配当 | 配当利回り | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
ニュース - Oragenics
日付 | 時間 | 情報元 | タイトル |
---|---|---|---|
2024/4/20 | 06:50 | Business Wire | Oragenics, Inc. Announces Notification of Noncompliance with.. |
2024/4/01 | 22:05 | Business Wire | Oragenics, Inc. Files 10K and Provides Company Update |
2024/3/18 | 20:00 | Business Wire | Oragenics Appoints James Kelly MD, Chief Medical Officer, to.. |
2024/3/07 | 06:24 | Edgar (US Regulatory) | Form SC 13G - Statement of acquisition of beneficial.. |
2024/3/05 | 21:45 | Business Wire | Oragenics, Inc. Prepares Drug for Phase II Clinical Trials.. |
2024/3/02 | 06:04 | Business Wire | Oragenics Announces Closing of Public Offering |
2024/3/01 | 06:41 | Edgar (US Regulatory) | Form 424B5 - Prospectus [Rule 424(b)(5)] |
2024/2/28 | 23:03 | Edgar (US Regulatory) | Form 8-K - Current report |
2024/2/28 | 11:25 | Business Wire | Oragenics Announces Pricing of Public Offering |
2024/2/28 | 07:09 | Edgar (US Regulatory) | Form FWP - Filing under Securities Act Rules 163/433 of free.. |
2024/2/28 | 07:04 | Edgar (US Regulatory) | Form 424B5 - Prospectus [Rule 424(b)(5)] |
2024/2/28 | 06:33 | Business Wire | Oragenics Announces Proposed Public Offering |
チャート - Oragenics
期間 † | 始値 | 高値 | 安値 | VWAP | 平均出来高 | 前日比 | % |
---|---|---|---|---|---|---|---|
1週 | 1.10 | 1.15 | 1.00 | 1.04 | 31,634 | -0.04 | -3.64% |
1ヶ月 | 1.31 | 1.42 | 1.00 | 1.16 | 52,451 | -0.25 | -19.08% |
3ヶ月 | 3.05 | 4.00 | 1.00 | 1.57 | 88,644 | -1.99 | -65.25% |
6ヶ月 | 3.87 | 7.74 | 1.00 | 2.08 | 55,974 | -2.81 | -72.61% |
1年 | 2.82 | 7.74 | 1.00 | 2.34 | 34,926 | -1.76 | -62.41% |
3年 | 49.20 | 69.00 | 1.00 | 37.72 | 1,143,246 | -48.14 | -97.85% |
5年 | 30.078 | 127.20 | 1.00 | 49.71 | 3,080,515 | -29.02 | -96.48% |